Ticker Scorecard - KALA Basics Company: Kala Pharmaceuticals, Inc. IPO Date: July 20, 2017 Sector: Healthcare Industry: Biotech Market Cap: $40.45M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.63% Avg Daily Range (30 D): $0.41 | 4.86% Avg Daily Range (90 D): $0.27 | 3.64% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 29 Avg Trade Size (Sh.) (30 D): 110 Avg Trade Size (Sh.) (90 D): 122 Institutional Trades Total Inst.Trades: 189 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $.64M Avg Inst. Trade (90 D): $.64M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.43M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 6.79K     News Feb 12, 2025 @ 1:00 PM KALA BIO Announces Chief Executive Officer Transit... Source: Kala Bio, Inc. Nov 27, 2024 @ 1:00 PM KALA BIO to Present at Piper Sandler 36th Annual H... Source: N/A May 29, 2024 @ 12:00 PM KALA BIO to Present at Jefferies Global Healthcare... Source: KALA BIO, Inc. Apr 4, 2024 @ 1:55 PM Does KALA BIO (KALA) Have the Potential to Rally 1... Source: Zacks Equity Research Mar 29, 2024 @ 12:00 PM KALA BIO Reports Fourth Quarter and Full Year 2023... Source: KALA BIO, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-12.28 $-1.93 $-3.16 Diluted EPS $-12.24 $-1.93 $-3.16 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -38.96M $ -8.95M $ -9.58M Operating Income / Loss $ -41.14M $ -9.99M $ -9.61M Cost of Revenue $ $ $ Net Cash Flow $ -6.86M $ -5M $ 5.72M PE Ratio     Splits Oct 21, 2022:   50:1 Aug 26, 2022:   1:1.00